IRB Fees


Institutional Review Board Review of Privately Funded
Research on Human Subjects

Institutional Review Board charges for review of human subject research funded by private industry sponsors (predominantly pharmaceutical or device manufacturing companies) will be as follows:

Full Board New Protocol Submission Non-Network and Network $2500
Continuing Review Non-Network and Network $650
Amendment Non-Network and Network $650
 
Expedited Review New Protocol Submission Non-Network and Network $650
Continuing Review Non-Network and Network $500
Amendment* Non-Network and Network $500
 
  Closure Fee Non-Network and Network $200

Note: At present, there will be no charge for:

  1. Emergency Use of an Investigational Drug or Biologic (http://www.fda.gov/RegulatoryInformation/Guidances/ucm126491.htm)
  2. Treatment Use of Investigational Drugs (http://www.fda.gov/RegulatoryInformation/Guidances/ucm126495.htm)
  3. Humanitarian Use Device (A HUD is a device that is intended to benefit patients in the treatment and diagnosis of diseases or conditions that affect or is manifested in fewer than 4,000 individuals in the United States per year)
  4. Studies in followup,data analysis

*IRB fees apply only to non-administrative changes of study documents requiring IRB review.


Administrative Review of Chesapeake IRB Approved Research on Human Subjects
 

Initial Review $2000
Continuing Review $500
Close Out $200
For Cause Audit $1000

 

IRB Archived File Request

Study teams are expected to maintain their own documents according to federal, institutional and departmental guidelines. In the event that a study team needs to access inactive, archived regulatory files maintained by the IRB, an IRB Archived File Request form must be submitted.

IRB Archived File Request Form